Neolithic and Medieval virus genomes reveal complex evolution of Hepatitis B

  1. Ben Krause-Kyora  Is a corresponding author
  2. Julian Susat
  3. Felix M Key
  4. Denise Kühnert
  5. Esther Bosse
  6. Alexander Immel
  7. Christoph Rinne
  8. Sabin-Christin Kornell
  9. Diego Yepes
  10. Sören Franzenburg
  11. Henrike O Heyne
  12. Thomas Meier
  13. Sandra Lösch
  14. Harald Meller
  15. Susanne Friederich
  16. Nicole Nicklisch
  17. Kurt W Alt
  18. Stefan Schreiber
  19. Andreas Tholey
  20. Alexander Herbig
  21. Almut Nebel
  22. Johannes Krause  Is a corresponding author
  1. Kiel University, Germany
  2. Max Planck Institute for the Science of Human History, Germany
  3. University Hospital Zurich, Switzerland
  4. Broad Institute, United States
  5. Heidelberg University, Germany
  6. University of Bern, Switzerland
  7. State Office for Heritage Management and Archaeology Saxony-Anhalt and State Museum of Prehistory, Germany

Abstract

The hepatitis B virus (HBV) is one of the most widespread human pathogens known today, yet its origin and evolutionary history are still unclear and controversial. Here, we report the analysis of three ancient HBV genomes recovered from human skeletons found at three different archaeological sites in Germany. We reconstructed two Neolithic and one medieval HBV genomes by de novo assembly from shotgun DNA sequencing data. Additionally, we observed HBV-specific peptides using paleo-proteomics. Our results show that HBV circulates in the European population for at least 7000 years. The Neolithic HBV genomes show a high genomic similarity to each other. In a phylogenetic network, they do not group with any human-associated HBV genome and are most closely related to those infecting African non-human primates. These ancient virus forms appear to represent distinct lineages that have no close relatives today and possibly went extinct. Our results reveal the great potential of ancient DNA from human skeletons in order to study the long-time evolution of blood borne viruses.

Data availability

Raw sequence read files have been deposited at the European Nucleotide Archive under accession no. PRJEB24921

The following data sets were generated

Article and author information

Author details

  1. Ben Krause-Kyora

    Institute of Clinical Molecular Biology, Kiel University, Kiel, Germany
    For correspondence
    b.krause-kyora@ikmb.uni-kiel.de
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-9435-2872
  2. Julian Susat

    Institute of Clinical Molecular Biology, Kiel University, Kiel, Germany
    Competing interests
    The authors declare that no competing interests exist.
  3. Felix M Key

    Department of Archeogenetics, Max Planck Institute for the Science of Human History, Jena, Germany
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-2812-6636
  4. Denise Kühnert

    Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zürich, Switzerland
    Competing interests
    The authors declare that no competing interests exist.
  5. Esther Bosse

    Institute of Clinical Molecular Biology, Kiel University, Kiel, Germany
    Competing interests
    The authors declare that no competing interests exist.
  6. Alexander Immel

    Institute of Clinical Molecular Biology, Kiel University, Kiel, Germany
    Competing interests
    The authors declare that no competing interests exist.
  7. Christoph Rinne

    Institute of Pre- and Protohistoric Archaeology, Kiel University, Kiel, Germany
    Competing interests
    The authors declare that no competing interests exist.
  8. Sabin-Christin Kornell

    Institute of Clinical Molecular Biology, Kiel University, Kiel, Germany
    Competing interests
    The authors declare that no competing interests exist.
  9. Diego Yepes

    Systematic Proteomics and Bioanalytics, Institute for Experimental Medicine, Kiel University, Kiel, Germany
    Competing interests
    The authors declare that no competing interests exist.
  10. Sören Franzenburg

    Institute of Clinical Molecular Biology, Kiel University, Kiel, Germany
    Competing interests
    The authors declare that no competing interests exist.
  11. Henrike O Heyne

    Stanley Center for Psychiatric Research, Broad Institute, Cambridge, United States
    Competing interests
    The authors declare that no competing interests exist.
  12. Thomas Meier

    Institute for Pre- and Protohistory and Near Eastern Archaeology, Heidelberg University, Heidelberg, Germany
    Competing interests
    The authors declare that no competing interests exist.
  13. Sandra Lösch

    Department of Physical Anthropology, Institute of Forensic Medicine, University of Bern, Bern, Switzerland
    Competing interests
    The authors declare that no competing interests exist.
  14. Harald Meller

    State Office for Heritage Management and Archaeology Saxony-Anhalt and State Museum of Prehistory, Halle, Germany
    Competing interests
    The authors declare that no competing interests exist.
  15. Susanne Friederich

    State Office for Heritage Management and Archaeology Saxony-Anhalt and State Museum of Prehistory, Halle, Germany
    Competing interests
    The authors declare that no competing interests exist.
  16. Nicole Nicklisch

    State Office for Heritage Management and Archaeology Saxony-Anhalt and State Museum of Prehistory, Halle, Germany
    Competing interests
    The authors declare that no competing interests exist.
  17. Kurt W Alt

    State Office for Heritage Management and Archaeology Saxony-Anhalt and State Museum of Prehistory, Halle, Germany
    Competing interests
    The authors declare that no competing interests exist.
  18. Stefan Schreiber

    Institute of Clinical Molecular Biology, Kiel University, Kiel, Germany
    Competing interests
    The authors declare that no competing interests exist.
  19. Andreas Tholey

    Systematic Proteomics and Bioanalytics, Institute for Experimental Medicine, Kiel University, Kiel, Germany
    Competing interests
    The authors declare that no competing interests exist.
  20. Alexander Herbig

    Department of Archaeogenetics, Max Planck Institute for the Science of Human History, Jena, Germany
    Competing interests
    The authors declare that no competing interests exist.
  21. Almut Nebel

    Institute of Clinical Molecular Biology, Kiel University, Kiel, Germany
    Competing interests
    The authors declare that no competing interests exist.
  22. Johannes Krause

    Department of Archaeogenetics, Max Planck Institute for the Science of Human History, Jena, Germany
    For correspondence
    krause@shh.mpg.de
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-9144-3920

Funding

European Research Council (APGREID)

  • Johannes Krause

Deutsche Forschungsgemeinschaft (Al 287-7-1)

  • Kurt W Alt

Deutsche Forschungsgemeinschaft (Me 3245/1-1)

  • Harald Meller

Collaborative Research Center (1266)

  • Ben Krause-Kyora

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Human subjects: Our human remains used are prehistoric European specimens. No consent from them can be required. No decedent groups claim responsibility or ancestry to those people.

Copyright

© 2018, Krause-Kyora et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 6,227
    views
  • 939
    downloads
  • 108
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Ben Krause-Kyora
  2. Julian Susat
  3. Felix M Key
  4. Denise Kühnert
  5. Esther Bosse
  6. Alexander Immel
  7. Christoph Rinne
  8. Sabin-Christin Kornell
  9. Diego Yepes
  10. Sören Franzenburg
  11. Henrike O Heyne
  12. Thomas Meier
  13. Sandra Lösch
  14. Harald Meller
  15. Susanne Friederich
  16. Nicole Nicklisch
  17. Kurt W Alt
  18. Stefan Schreiber
  19. Andreas Tholey
  20. Alexander Herbig
  21. Almut Nebel
  22. Johannes Krause
(2018)
Neolithic and Medieval virus genomes reveal complex evolution of Hepatitis B
eLife 7:e36666.
https://doi.org/10.7554/eLife.36666

Share this article

https://doi.org/10.7554/eLife.36666

Further reading

    1. Chromosomes and Gene Expression
    2. Genetics and Genomics
    Omid Gholamalamdari, Tom van Schaik ... Andrew S Belmont
    Research Article

    Models of nuclear genome organization often propose a binary division into active versus inactive compartments yet typically overlook nuclear bodies. Here, we integrated analysis of sequencing and image-based data to compare genome organization in four human cell types relative to three different nuclear locales: the nuclear lamina, nuclear speckles, and nucleoli. Although gene expression correlates mostly with nuclear speckle proximity, DNA replication timing correlates with proximity to multiple nuclear locales. Speckle attachment regions emerge as DNA replication initiation zones whose replication timing and gene composition vary with their attachment frequency. Most facultative LADs retain a partially repressed state as iLADs, despite their positioning in the nuclear interior. Knock out of two lamina proteins, Lamin A and LBR, causes a shift of H3K9me3-enriched LADs from lamina to nucleolus, and a reciprocal relocation of H3K27me3-enriched partially repressed iLADs from nucleolus to lamina. Thus, these partially repressed iLADs appear to compete with LADs for nuclear lamina attachment with consequences for replication timing. The nuclear organization in adherent cells is polarized with nuclear bodies and genomic regions segregating both radially and relative to the equatorial plane. Together, our results underscore the importance of considering genome organization relative to nuclear locales for a more complete understanding of the spatial and functional organization of the human genome.

    1. Cell Biology
    2. Genetics and Genomics
    Keva Li, Nicholas Tolman ... UK Biobank Eye and Vision Consortium
    Research Article

    A glaucoma polygenic risk score (PRS) can effectively identify disease risk, but some individuals with high PRS do not develop glaucoma. Factors contributing to this resilience remain unclear. Using 4,658 glaucoma cases and 113,040 controls in a cross-sectional study of the UK Biobank, we investigated whether plasma metabolites enhanced glaucoma prediction and if a metabolomic signature of resilience in high-genetic-risk individuals existed. Logistic regression models incorporating 168 NMR-based metabolites into PRS-based glaucoma assessments were developed, with multiple comparison corrections applied. While metabolites weakly predicted glaucoma (Area Under the Curve = 0.579), they offered marginal prediction improvement in PRS-only-based models (p=0.004). We identified a metabolomic signature associated with resilience in the top glaucoma PRS decile, with elevated glycolysis-related metabolites—lactate (p=8.8E-12), pyruvate (p=1.9E-10), and citrate (p=0.02)—linked to reduced glaucoma prevalence. These metabolites combined significantly modified the PRS-glaucoma relationship (Pinteraction = 0.011). Higher total resilience metabolite levels within the highest PRS quartile corresponded to lower glaucoma prevalence (Odds Ratiohighest vs. lowest total resilience metabolite quartile=0.71, 95% Confidence Interval = 0.64–0.80). As pyruvate is a foundational metabolite linking glycolysis to tricarboxylic acid cycle metabolism and ATP generation, we pursued experimental validation for this putative resilience biomarker in a human-relevant Mus musculus glaucoma model. Dietary pyruvate mitigated elevated intraocular pressure (p=0.002) and optic nerve damage (p<0.0003) in Lmx1bV265D mice. These findings highlight the protective role of pyruvate-related metabolism against glaucoma and suggest potential avenues for therapeutic intervention.